Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Monday, October 08, 2012

Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study

http://www.google.com/gwt/x?source=reader&u=http://www.sciencedirect.com/science/article/pii/S0049384812007402&ei=kCNzUMfVIIn6xALazYAY&wsc=bf

Sent from my iPhone

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments ( Atom )